Russell Investments Group Ltd. trimmed its holdings in shares of PACS Group, Inc. (NYSE:PACS – Free Report) by 16.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 306,542 shares of the company’s stock after selling 59,860 shares during the period. Russell Investments Group Ltd.’s holdings in PACS Group were worth $12,737,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also modified their holdings of the company. Cantor Fitzgerald Investment Advisors L.P. acquired a new position in PACS Group in the third quarter valued at $1,920,000. Squarepoint Ops LLC boosted its stake in PACS Group by 94.7% in the 2nd quarter. Squarepoint Ops LLC now owns 59,523 shares of the company’s stock worth $2,538,000 after buying an additional 28,945 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in PACS Group in the 2nd quarter worth about $1,893,000. Engineers Gate Manager LP acquired a new stake in PACS Group in the 2nd quarter worth about $1,132,000. Finally, Ellsworth Advisors LLC purchased a new stake in PACS Group in the 3rd quarter valued at about $914,000.
PACS Group Stock Up 1.4%
PACS opened at $43.63 on Friday. The firm has a 50 day moving average price of $45.45 and a 200 day moving average price of $40.65. The company has a market cap of $6.92 billion, a PE ratio of 24.65, a price-to-earnings-growth ratio of 1.59 and a beta of -0.14. PACS Group, Inc. has a 1 year low of $24.61 and a 1 year high of $51.68. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.80 and a current ratio of 0.80.
PACS Group (NYSE:PACS – Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.58 by $0.05. The firm had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.46 billion. PACS Group had a net margin of 4.87% and a return on equity of 31.98%. Sell-side analysts expect that PACS Group, Inc. will post 2.05 earnings per share for the current year.
Insider Buying and Selling at PACS Group
In other news, CAO Michelle Lewis sold 3,172 shares of the firm’s stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $50.06, for a total value of $158,790.32. Following the transaction, the chief accounting officer owned 340,338 shares of the company’s stock, valued at approximately $17,037,320.28. This trade represents a 0.92% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Joshua Jergensen sold 40,000 shares of PACS Group stock in a transaction on Wednesday, November 11th. The shares were sold at an average price of $50.11, for a total transaction of $2,004,400.00. Following the transaction, the chief operating officer owned 2,416,320 shares in the company, valued at $121,081,795.20. The trade was a 1.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,395,000 shares of company stock worth $64,793,252 over the last three months. 70.10% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
A number of research firms have recently commented on PACS. JPMorgan Chase & Co. upped their price objective on shares of PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a research note on Friday, September 4th. Royal Bank Of Canada raised their target price on shares of PACS Group from $57.00 to $64.00 and gave the stock an “outperform” rating in a research report on Monday, November 16th. UBS Group raised their target price on shares of PACS Group from $60.00 to $67.00 and gave the stock a “buy” rating in a research report on Thursday, November 5th. Stephens boosted their target price on shares of PACS Group from $60.00 to $64.00 and gave the company an “overweight” rating in a report on Thursday, November 5th. Finally, Wall Street Zen upgraded shares of PACS Group from a “buy” rating to a “strong-buy” rating in a report on Saturday. Seven equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, PACS Group has a consensus rating of “Moderate Buy” and an average price target of $62.50.
Read Our Latest Report on PACS Group
PACS Group Profile
PACS Group, Inc. is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs. Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.
Read More
- Five stocks we like better than PACS Group
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Want to see what other hedge funds are holding PACS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PACS Group, Inc. (NYSE:PACS – Free Report).
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
